DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

HC Wainwright & Co. Maintains Buy on Kala Pharmaceuticals, Raises Price Target to $13

HC Wainwright & Co. analyst Yi Chen maintains Kala Pharmaceuticals (NASDAQ:KALA) with a Buy and raises the price target from $10 to $13.

Benzinga · 03/18/2020 11:10

HC Wainwright & Co. analyst Yi Chen maintains Kala Pharmaceuticals (NASDAQ:KALA) with a Buy and raises the price target from $10 to $13.